YDESYD Bio Ltd
Is the business good?
How good a business is YDES?
YD Bio Ltd spent more than it took in: an operating loss of $5.3M on $597K of revenue, fiscal year to FY2025.
Operating loss · on $597K of revenue · fiscal year to FY2025
- Share count, year on year
- +3.1%
Share count, year on year · shareholders own a smaller slice than a year ago
- Gross margin
- 28%
Gross margin
| Year | Operating margin |
|---|---|
| FY2023 | −2.8% |
| FY2024 | −286% |
| FY2025 | −883% |
Details›
- Gross marginfiscal year to FY2025
- 28%
- Operating marginfiscal year to FY2025
- −883%
- Net marginfiscal year to FY2025
- −1393%
- Free cash flow margin
- −1347%
- R&D as % of revenue
- 268%
- Revenue, trailing twelve months
- $597K
- Free cash flow, trailing twelve months
- −$8.0M
- Net income, trailing twelve months
- −$8.3M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Customers and suppliers
Who buys from YDES and who it buys from, as the companies report it.
- Customer B32%
Share of revenue · FY2025 20-F
- Customer C13%
Share of revenue · FY2025 20-F
None disclosed.
A company has to disclose every customer behind 10% or more of its revenue. Each share comes from the latest annual report of the company that states it and shows on both companies’ pages; YDES’s own figures are from its FY2025 20-F. Smaller customers and suppliers go unreported.
Biotechnology
The closest names by size in the same industry